Immune-LCM used for retrieval of Factor VIII-positive endothelial cells from FFPE tissue sections. (a) Factor VIII+ endothelial cells in the head and neck carcinoma. (b) Retrieval of Factor VIII-positive endothelial cells. This step is performed after dissecting blood cells in Factor VIII-positive capillaries.
